Cargando…

Molecular heterogeneity of CD30+ diffuse large B-cell lymphoma with prognostic significance and therapeutic implication

Detalles Bibliográficos
Autores principales:	Huo, Yu-Jia, Xu, Peng-Peng, Fu, Di, Yi, Hong-Mei, Huang, Yao-Hui, Wang, Li, Wang, Nan, Ji, Meng-Meng, Liu, Qing-Xiao, Shi, Qing, Wang, Shuo, Cheng, Shu, Feng, Yan, Zhao, Wei-Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964673/ https://www.ncbi.nlm.nih.gov/pubmed/35351868 http://dx.doi.org/10.1038/s41408-022-00644-2

Ejemplares similares

Dynamic change of soluble interleukin-2 receptor distinguished molecular heterogeneity and microenvironment alterations in diffuse large B-cell lymphoma
por: Huo, Yu-Jia, et al.
Publicado: (2022)

Anti-CD30 chimeric antigen receptor T cell therapy for relapsed/refractory CD30(+) lymphoma patients
por: Wang, D., et al.
Publicado: (2020)

Prognostic significance of CD30 expression in nasal natural killer/T-cell lymphoma
por: Wang, Guan-Nan, et al.
Publicado: (2017)

The clinical features, prognostic significance, and immune heterogeneity of CD37 in diffuse gliomas
por: Yan, Xuejun, et al.
Publicado: (2021)

Clinical and prognostic features of primary retroperitoneal diffuse large B-cell lymphoma: a single-center experience in China
por: Liu, Xiao-Hong, et al.
Publicado: (2021)

Primary Cutaneous CD30+ Anaplastic Lymphoma: A Case Report and Reappraisal
por: Sen, Sumit, et al.
Publicado: (2013)

Prognostic impact of a past or synchronous second cancer in diffuse large B cell lymphoma
por: Tanba, Kazuna, et al.
Publicado: (2018)

Molecular Heterogeneity in Localized Diffuse Large B-Cell Lymphoma
por: Qin, Wei, et al.
Publicado: (2021)

Prognostic significance of chromosome arm 1q gain and methylation class in molecularly defined diffuse leptomeningeal glioneuronal tumor
por: Chiang, Jason, et al.
Publicado: (2022)

Prognostic value of tissue inhibitor of metalloproteinase-matrix metalloproteinase biomarkers at 30 days in patients with acute myocardial infarction without reperfusion therapy
por: Pang, Hui-Fang, et al.
Publicado: (2021)

CD10-positive mantle cell lymphoma: clinicopathologic and prognostic study of 30 cases
por: Xu, Jie, et al.
Publicado: (2017)

Long-term safety and efficacy of CART-20 cells in patients with refractory or relapsed B-cell non-Hodgkin lymphoma: 5-years follow-up results of the phase I and IIa trials
por: Zhang, Wen-ying, et al.
Publicado: (2017)

Successful Management of a Rare Case of Humerus Non-Hodgkin's Lymphoma in Rapid Progress
por: Liu, Shu-Zhong, et al.
Publicado: (2018)

CD19 and CD30 CAR T-Cell Immunotherapy for High-Risk Classical Hodgkin’s Lymphoma
por: Xue, YuanBo, et al.
Publicado: (2021)

An 11 years delayed diagnosis of primary pulmonary diffuse large B cell lymphoma
por: Yu, Jin-Yan, et al.
Publicado: (2019)

Characterization and prognostic significance of alternative splicing events in lower‐grade diffuse gliomas
por: Zhao, Zheng, et al.
Publicado: (2020)

Neurolymphomatosis caused by diffuse large B-cell lymphoma presenting as isolated brachial plexopathy
por: Li, Heng, et al.
Publicado: (2019)

Glofitamab therapy for diffuse large B cell lymphoma: latest updates from the 2022 ASH Annual Meeting
por: Wang, Chaoyu, et al.
Publicado: (2023)

Mutational heterogeneity of angioimmunoblastic T-cell lymphoma indicates distinct lymphomagenic pathways
por: Willemsen, Mathijs, et al.
Publicado: (2018)

Intestinal Mucosal-Associated Lymphoid Tissue Lymphoma Mimicked Cryptogenic Multifocal Ulcerous Stenosing Enteritis
por: Shen, Kai-Ni, et al.
Publicado: (2018)

Sub-acute toxicity of licorice-sargassum extract in Sprague-Dawley rats: biochemical, histopathological, and pharmacokinetic studies
por: Jing, Xinyue, et al.
Publicado: (2022)

FTL004, an anti-CD38 mAb with negligible RBC binding and enhanced pro-apoptotic activity, is a novel candidate for treatments of multiple myeloma and non-Hodgkin lymphoma
por: Zhang, Guangbing, et al.
Publicado: (2022)

Prognostic significance of neutrophil-to-lymphocyte ratio in diffuse large B-cell lymphoma: A meta-analysis
por: Wang, Jin, et al.
Publicado: (2017)

CD23 mediated the induction of pro-inflammatory cytokines Interleukin-1 beta and tumor necrosis factors-alpha in Aspergillus fumigatus keratitis
por: Yan, Hai-Jing, et al.
Publicado: (2021)

Prognostic significance of lymphocyte‐to‐monocyte ratio in diffuse large B‐cell lymphoma: a systematic review and meta‐analysis
por: Xia, Wen‐Kai, et al.
Publicado: (2016)

Prognostic Significance of Ribosome-related Genes Signature in Diffuse Large B Cell Lymphoma
por: Wu, Wenqi, et al.
Publicado: (2023)

Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma
por: Shen, Rong, et al.
Publicado: (2023)

Guillain-Barre Syndrome Complicated on Postoperation on Renal Carcinoma and Meningioma
por: Xu, Shuai, et al.
Publicado: (2018)

Prolonged and recurrent hypoglycemia induced by trimethoprim-sulfamethoxazole in a Hodgkin lymphoma patient with Pneumocystis carinii pneumonia
por: Wang, Bing-Jie, et al.
Publicado: (2021)

A Case of Primary Vitreous Retinal Lymphoma
por: Li, Meng-Da, et al.
Publicado: (2018)

CD30 expression is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type
por: Li, Pengfei, et al.
Publicado: (2014)

Identification of three small nucleolar RNAs (snoRNAs) as potential prognostic markers in diffuse large B‐cell lymphoma
por: Li, Mei‐wei, et al.
Publicado: (2022)

Reply to: Comments on “Nomograms based on inflammatory biomarkers for predicting tumor grade and micro-vascular invasion in stage I/II hepatocellular carcinoma”
por: Li, Peng, et al.
Publicado: (2019)

Unravelling the hidden heterogeneities of diffuse large B-cell lymphoma based on coupled two-way clustering
por: Zhang, Wei, et al.
Publicado: (2007)

Clinical Features and Prognostic Significance of NOTCH1 Mutations in Diffuse Large B-Cell Lymphoma
por: Li, Zhongqi, et al.
Publicado: (2021)

Relapsed Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type
por: Wu, Shaohua, et al.
Publicado: (2017)

Systemic diffuse large B-cell lymphoma with bilateral ciliary body involvement
por: Di, Yu, et al.
Publicado: (2020)

Systemic lupus erythematosus with diffuse alveolar hemorrhage
por: Huo, Rongxiu, et al.
Publicado: (2023)

Inhibition of the STAT3 target SGK1 sensitizes diffuse large B cell lymphoma cells to AKT inhibitors
por: Lu, Li, et al.
Publicado: (2019)

Rapid tumor regression from PD-1 inhibition after anti-CD19 chimeric antigen receptor T-cell therapy in refractory diffuse large B-cell lymphoma
por: Hill, Brian T., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_m69at696qcjfliv1g6hh05r7v4